Man Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $543K | Sell |
20,479
-6,572
| -24% | -$174K | ﹤0.01% | 1586 |
|
|
2025
Q1 | $653K | Sell |
27,051
-421,681
| -94% | -$10.2M | ﹤0.01% | 1490 |
|
|
2024
Q4 | $18.1M | Buy |
448,732
+435,813
| +3,373% | +$17.5M | 0.05% | 406 |
|
|
2024
Q3 | $818K | Sell |
12,919
-13,820
| -52% | -$875K | ﹤0.01% | 1412 |
|
|
2024
Q2 | $1.42M | Buy |
+26,739
| New | +$1.42M | ﹤0.01% | 1318 |
|
|
2023
Q2 | – | Hold |
0
| – | -$195K | – | 2187 |
|
|
2023
Q1 | – | Sell |
-14,953
| Closed | -$141K | – | 1786 |
|
|
2022
Q4 | $141K | Sell |
14,953
-167,730
| -92% | -$1.58M | ﹤0.01% | 1837 |
|
|
2022
Q3 | $497K | Buy |
+182,683
| New | +$497K | ﹤0.01% | 1493 |
|
|
2022
Q2 | – | Sell |
-12,400
| Closed | -$37K | – | 1476 |
|
|
2022
Q1 | $37K | Buy |
+12,400
| New | +$37K | ﹤0.01% | 1996 |
|
|
2018
Q4 | – | Sell |
-12,087
| Closed | -$211K | – | 2112 |
|
|
2018
Q3 | $211K | Buy |
+12,087
| New | +$211K | ﹤0.01% | 2001 |
|